Cholecalciferol supplementation effectively improved tertiary hyperparathyroidism, FGF23 resistance and lowered coronary calcification score: a prospective study.

Hu, Shu-Meng; Bai, Yang-Juan; Li, Ya-Mei; Tao, Ye; Wang, Xian-Ding; Lin, Tao; Wang, Lan-Lan; Shi, Yun-Ying

Hu, Shu-Meng; Bai, Yang-Juan; Li, Ya-Mei; Tao, Ye; Wang, Xian-Ding; Lin, Tao; Wang, Lan-Lan; Shi, Yun-Ying.

Affiliation

Hu SM; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Bai YJ; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li YM; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tao Y; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang XD; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lin T; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang LL; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Shi YY; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Endocr Connect ; 11(8)2022 Aug 01.

Article in En | MEDLINE | ID: mdl-35904219

Key words

alpha Klotho; coronary calcification; fibroblast growth factor 23; kidney transplantation; secondary hyperparathyroidism; vitamin D

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Endocr Connect Year: 2022 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google